| scholarly article | Q13442814 |
| P50 | author | Ole Petter Rekvig | Q72933901 |
| P2860 | cites work | Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry | Q24563454 |
| CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 | ||
| Chromatin: constructing the big picture | Q24632812 | ||
| The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy | Q24633214 | ||
| Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus | Q26776493 | ||
| Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks | Q26822373 | ||
| Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners? | Q26825971 | ||
| The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint? | Q28085243 | ||
| Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology | Q28185318 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Reflections on the clonal-selection theory | Q28250469 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Decoding the patterns of self and nonself by the innate immune system | Q29618448 | ||
| DNA-damaging autoantibodies and cancer: the lupus butterfly theory | Q30251723 | ||
| Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years | Q41698087 | ||
| Antibodies to DNA. | Q41756806 | ||
| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus | Q41977234 | ||
| Preferred DNA-binding-sites of polyomavirus large T-antigen | Q42067021 | ||
| Clinical and laboratory observation systemic lupus erythematosus and acute lymphocytic leukemia: An unusual case | Q42145232 | ||
| Infections and systemic lupus erythematosus | Q42220143 | ||
| Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia | Q42257730 | ||
| Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study | Q42553554 | ||
| Lupus at the molecular level | Q42772178 | ||
| Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study | Q44933874 | ||
| Autoimmunity to DNA and nucleosomes in binary tetracycline-regulated polyomavirus T-Ag transgenic mice | Q45178629 | ||
| Antibodies to dsDNA are produced during primary BK virus infection in man, indicating that anti-dsDNA antibodies may be related to virus replication in vivo | Q45778041 | ||
| Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort | Q45812853 | ||
| Antibodies to eukaryotic, including autologous, native DNA are produced during BK virus infection, but not after immunization with non-infectious BK DNA. | Q45874641 | ||
| Immunogenicity of Z-DNA depends on the size of polynucleotide presented in complexes with methylated BSA. | Q47412754 | ||
| Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. | Q47825994 | ||
| Comparison of the frequencies of arginines in heavy chain CDR3 of antibodies expressed in the primary B-cell repertoires of autoimmune-prone and normal mice | Q48021817 | ||
| A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice | Q48312760 | ||
| Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. | Q51056997 | ||
| Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. | Q51747118 | ||
| The site and stage of anti-DNA B-cell deletion. | Q52210540 | ||
| Systemic lupus erythematosus. | Q53202066 | ||
| Systemic lupus erythematosus. | Q53495545 | ||
| Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. | Q54651702 | ||
| Cellular requirements for anti-DNA production induced in mice by immunization with bacterial DNA. | Q54710410 | ||
| Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. | Q54794605 | ||
| Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus | Q55671565 | ||
| Receptor editing: an approach by autoreactive B cells to escape tolerance | Q36361497 | ||
| Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen | Q36362919 | ||
| Regulation of anti-DNA B cells in recombination-activating gene-deficient mice | Q36401575 | ||
| Immunity and autoimmunity induced by polyomaviruses: clinical, experimental and theoretical aspects | Q36454157 | ||
| Editing and escape from editing in anti-DNA B cells | Q36499182 | ||
| Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity | Q36588860 | ||
| Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors | Q36727307 | ||
| A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry | Q36807319 | ||
| A relationship between the helical twist of DNA and the ordered positioning of nucleosomes in all eukaryotic cells | Q36820711 | ||
| Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity | Q36990647 | ||
| Chromatin organization and virus gene expression | Q37100169 | ||
| Epstein-Barr virus in systemic autoimmune diseases | Q37154847 | ||
| Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value | Q37209078 | ||
| The role of innate immunity in the induction of autoimmunity | Q37245531 | ||
| Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity | Q37272155 | ||
| Predictors of major infections in systemic lupus erythematosus | Q37350893 | ||
| Serologic laboratory findings in malignancy | Q37401677 | ||
| The place of William Osler in the description of systemic lupus erythematosus | Q37438428 | ||
| Cytomegalovirus infection in childhood-onset systemic lupus erythematosus | Q37577044 | ||
| Antibodies to DNA: infection or genetics? | Q37625581 | ||
| Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort | Q37640271 | ||
| Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease | Q37708458 | ||
| Genetics of SLE: evidence from mouse models | Q37741802 | ||
| Medical conditions associated with a positive anti-double-stranded deoxyribonucleic acid. | Q37773165 | ||
| Chromatin organization: form to function | Q38070285 | ||
| Lupus nephritis: enigmas, conflicting models and an emerging concept | Q38113421 | ||
| The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved | Q38206945 | ||
| DNA mimic proteins: functions, structures, and bioinformatic analysis | Q38207089 | ||
| Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus | Q38237868 | ||
| A viral DNA-binding domain elicits anti-DNA antibodies of different specificities. | Q38333347 | ||
| Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis | Q38396871 | ||
| The anti-DNA antibody: origin and impact, dogmas and controversies | Q38512653 | ||
| Anti-DNA antibodies--quintessential biomarkers of SLE. | Q38637632 | ||
| International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphos | Q38657993 | ||
| Future Perspectives on Pathogenesis of Lupus Nephritis: Facts, Problems, and Potential Causal Therapy Modalities | Q38803720 | ||
| Success and failure of biological treatment in systemic lupus erythematosus: A critical analysis | Q38884826 | ||
| The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned | Q38927117 | ||
| New insights into the immunopathogenesis of systemic lupus erythematosus. | Q39016144 | ||
| Expanding the B Cell-Centric View of Systemic Lupus Erythematosus | Q39169139 | ||
| An update on lupus animal models | Q39326265 | ||
| Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors | Q39783214 | ||
| The serological activity of desoxypentosenucleic acids | Q39975973 | ||
| Origin and anti-tumor effects of anti-dsDNA autoantibodies in cancer patients and tumor-bearing mice | Q40427260 | ||
| Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. | Q40523180 | ||
| Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. | Q40605206 | ||
| Infection and autoimmunity: a story of the host, the pathogen, and the copathogen | Q40651853 | ||
| Genetic and structural evidence for antigen selection of anti-DNA antibodies. | Q40661152 | ||
| Monoclonal anti-DNA antibodies: structure, specificity, and biology | Q41302752 | ||
| T cell clonal anergy | Q41514572 | ||
| Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry | Q30663976 | ||
| How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases? | Q31059502 | ||
| Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies | Q31125878 | ||
| Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis | Q33186999 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66 | Q33391806 | ||
| In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones | Q33676884 | ||
| Infection in systemic lupus erythematosus: friend or foe? | Q33696879 | ||
| The evolution of human anti-double-stranded DNA autoantibodies | Q33878890 | ||
| The structure of DNA in the nucleosome core | Q33965908 | ||
| Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? | Q34175687 | ||
| Immune responses to DNA in normal and aberrant immunity | Q34242598 | ||
| Systemic lupus erythematosus I: historical aspects | Q34256642 | ||
| CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
| Immunostimulatory DNA sequences necessary for effective intradermal gene immunization | Q34384185 | ||
| The blood nucleome in the pathogenesis of SLE | Q34415680 | ||
| Immunochemistry of DNA. | Q34423748 | ||
| The history of lupus erythematosus | Q34583403 | ||
| The history of lupus erythematosus. From Hippocrates to Osler | Q34684696 | ||
| Genetics of autoimmune diseases in humans and in animal models | Q34987317 | ||
| Evolving from reductionism to holism: is there a future for systems medicine? | Q35000776 | ||
| Lupus nephritis: a nucleosome waste disposal defect? | Q35039769 | ||
| Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation | Q35092331 | ||
| Enhancing immunogenicity by CpG DNA. | Q35138928 | ||
| SLE and infections | Q35148608 | ||
| Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. | Q35554410 | ||
| Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis | Q35632045 | ||
| An Unusual Mimicker of Systemic Lupus Erythematosus: A Case Report | Q35763572 | ||
| Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice | Q35931319 | ||
| Infection and Lupus: Which Causes Which? | Q35948285 | ||
| T cells and B cells in lupus nephritis | Q36019347 | ||
| American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis | Q36221407 | ||
| Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids | Q36344641 | ||
| Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation | Q36350233 | ||
| Specificity and immunochemical properties of antibodies to bacterial DNA | Q64389308 | ||
| On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice | Q64389756 | ||
| Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS) | Q64389818 | ||
| Immunochemical properties of anti-DNA antibodies in the sera of patients with Escherichia coli bacteremia | Q67572835 | ||
| Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity | Q67897243 | ||
| Antibodies to DNA | Q68864733 | ||
| Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA | Q69485992 | ||
| The effect of anti-Z-DNA antibodies on the B-DNA-Z-DNA equilibrium | Q69491682 | ||
| Visualization of the bent helix in kinetoplast DNA by electron microscopy | Q69587892 | ||
| Terminology and iconography of lupus erythematosus. A historical vignette | Q70164914 | ||
| Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice | Q70466622 | ||
| Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma | Q71017849 | ||
| Responsiveness of autoimmune and normal mice to nucleic acid antigens | Q71251892 | ||
| Human polyomavirus BK and immunogenicity of mammalian DNA: a conceptual framework | Q71960247 | ||
| Nucleosomes and histones are present in glomerular deposits in human lupus nephritis | Q73060242 | ||
| Editing disease-associated autoantibodies | Q73115270 | ||
| Deficient expression of antibodies specific for bacterial DNA by patients with systemic lupus erythematosus | Q73345707 | ||
| Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer | Q73400496 | ||
| The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma | Q73505457 | ||
| Why the difference between B-DNA and Z-DNA? | Q73696150 | ||
| Analysis of B/W-DNA 16 V(H) gene expression following DNA-peptide immunization | Q73696155 | ||
| Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis | Q73712017 | ||
| Anti-dsDNA antibodies in sarcoidosis | Q73775163 | ||
| [Demonstration in the blood of patients with disseminated lupus erythematosus a substance determining a precipitation reaction with desoxyribonucleic acid] | Q74606156 | ||
| New serological methods for the detection of the L.E. factor | Q74768814 | ||
| A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus | Q74795925 | ||
| Complement fixation with cell nuclei and DNA in lupus erythematosus | Q74795928 | ||
| Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter | Q77328508 | ||
| Glomerular expression of large polyomavirus T antigen in binary tet-off regulated transgenic mice induces apoptosis, release of chromatin and initiates a lupus-like nephritis | Q80844170 | ||
| THE SENSITIZING PROPERTIES OF THE NUCLEIC ACIDS AND THEIR DERIVATIVES | Q81219147 | ||
| The binding of sera of patients with SLE to bacterial and mammalian DNA | Q81505571 | ||
| An anti-double-stranded DNA monoclonal antibody induced by tumor cell-derived DNA inhibits the growth of tumor in vitro and in vivo via triggering apoptosis | Q81545266 | ||
| When autologous chromatin becomes a foe | Q84973433 | ||
| Connective tissue diseases: Is SLE many single-organ diseases or an overlapping spectrum? | Q87239379 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 387 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas. | |
| P478 | volume | 9 |
| Q90403019 | Cardiac Tamponade in an 18-year-old Male with Undiagnosed Systemic Lupus Erythematosus |
| Q94544346 | Hydrogen peroxide and disease: towards a unified system of pathogenesis and therapeutics |
| Q94553977 | Interaction of miR-181b and IFNA1 Polymorphisms on the Risk of Systemic Lupus Erythematosus |
| Q64972429 | The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. |
Search more.